Breast cancer drug could help more patients, researchers say: ‘It makes, for the first time, a targetable population’

It belongs to a relatively new class of drugs called antibody-drug conjugates. Read More

Read More?

Post is imported from RSS feed, by one of our guest editors. G6 does not edit or moderate the content. G6 is not responsible for your actions. No rights owned by G6. To remove the post, please email us at [email protected]

No Comments

Sorry, the comment form is closed at this time.